These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9393682)

  • 1. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter.
    Balan I; Alarco AM; Raymond M
    J Bacteriol; 1997 Dec; 179(23):7210-8. PubMed ID: 9393682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fourth gene from the Candida albicans CDR family of ABC transporters.
    Franz R; Michel S; Morschhäuser J
    Gene; 1998 Oct; 220(1-2):91-8. PubMed ID: 9767132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Sanglard D; Ischer F; Monod M; Bille J
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators.
    Smriti ; Krishnamurthy S; Dixit BL; Gupta CM; Milewski S; Prasad R
    Yeast; 2002 Mar; 19(4):303-18. PubMed ID: 11870854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system.
    Krishnamurthy S; Chatterjee U; Gupta V; Prasad R; Das P; Snehlata P; Hasnain SE; Prasad R
    Yeast; 1998 Apr; 14(6):535-50. PubMed ID: 9605504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Ste6p/P-glycoprotein homologue from the asexual yeast Candida albicans transports the a-factor mating pheromone in Saccharomyces cerevisiae.
    Raymond M; Dignard D; Alarco AM; Mainville N; Magee BB; Thomas DY
    Mol Microbiol; 1998 Feb; 27(3):587-98. PubMed ID: 9489670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
    Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
    J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaALK8, an alkane assimilating cytochrome P450, confers multidrug resistance when expressed in a hypersensitive strain of Candida albicans.
    Panwar SL; Krishnamurthy S; Gupta V; Alarco AM; Raymond M; Sanglard D; Prasad R
    Yeast; 2001 Sep; 18(12):1117-29. PubMed ID: 11536334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeras of the ABC drug transporter Cdr1p reveal functional indispensability of transmembrane domains and nucleotide-binding domains, but transmembrane segment 12 is replaceable with the corresponding homologous region of the non-drug transporter Cdr3p.
    Saini P; Gaur NA; Prasad R
    Microbiology (Reading); 2006 May; 152(Pt 5):1559-1573. PubMed ID: 16622073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function.
    Tanabe K; Lamping E; Nagi M; Okawada A; Holmes AR; Miyazaki Y; Cannon RD; Monk BC; Niimi M
    Mol Microbiol; 2011 Oct; 82(2):416-33. PubMed ID: 21895791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
    Mukherjee PK; Chandra J; Kuhn DM; Ghannoum MA
    Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae.
    Talibi D; Raymond M
    J Bacteriol; 1999 Jan; 181(1):231-40. PubMed ID: 9864335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
    Moran GP; Sanglard D; Donnelly SM; Shanley DB; Sullivan DJ; Coleman DC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1819-30. PubMed ID: 9661028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
    Holmes AR; Tsao S; Ong SW; Lamping E; Niimi K; Monk BC; Niimi M; Kaneko A; Holland BR; Schmid J; Cannon RD
    Mol Microbiol; 2006 Oct; 62(1):170-86. PubMed ID: 16942600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
    Sanglard D; Ischer F; Monod M; Bille J
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin.
    Schuetzer-Muehlbauer M; Willinger B; Krapf G; Enzinger S; Presterl E; Kuchler K
    Mol Microbiol; 2003 Apr; 48(1):225-35. PubMed ID: 12657057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.